Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation: The Registry to Evaluate the HeartWare Left Ventricular Assist System. Circ.Heart Fail. 2020. Leber [...] assist devices-5-year follow-up. J.Thorac.Dis. 2018. Wert L, et al. Treatment of an Intercostal Left Ventricular Assist Device Prolapse by Upgrading From HeartMate II to HeartMate 3. Artif.Organs. 2018 [...] Statistical approach to quality assessment in liver transplantation. Langenbecks Arch Surg. 2018. Sommerer C, et al. Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine

patients with a cardiovascular disease. Hereby, the aim is to provide a guide to help researchers in their experimental design to translate bench findings to clinical routine taking the replacement, reduction [...] For this reason, I am extremely pleased to shape the future of Fraunhofer ITEM together with Professor Thum, to provide decisive scientific impulse and to bring it to application," emphasizes Professor Krug [...] likely also translatable to human models. Results translatable to human tissues? In the context of MEGFIB the research team aims to translate the efficacy of the Meg3 inhibitor to human cells and tissues

physiological protein function as well as the gain of cytotoxic properties inducing neuronal death. To date, the mechanisms that drive protein aggregation are not completely understood, and there is no effective [...] workshop will highlight the molecular mechanisms underlying pathological protein aggregation leading to neurodegeneration and present current research on the development of novel therapeutic strategies in

Geyer S. Elderly women after breast cancer diagnosis: Factors affecting their decision (not) to return to work. (Kongress DGMS/ESHMS, Hannover 2012) Noeres D, von Garmissen A, Neises M. Geyer S . Breast [...] Park-Simon TW, Sahiti E, Geyer S (2024). Social participation of women with breast cancer compared to the general population 5 years after primary surgery-what role do medical data and cancer-related [...] Noeres D , Park-Simon TW, Grabow J, Sperlich S, Koch-Gießelmann H, Jaunzeme J, Geyer S (2013). Return to work after treatment for primary breast cancer over a six-year period: Results from a prospective study

stimulation (DBS). In this paper, we summarise new developments described in the guidelines with respect to assessment and treatment of tics. Further, summary findings from a recent survey conducted amongst [...] Behandlung des Tourette-Syndroms mit dem neuen Medikament ABX-1431 First patient dosed in Phase 2 trial to evaluate the efficacy of ABX-1431 in treating adult patients with Tourette Syndrome SAN DIEGO, October [...] wird in vier Teilen à ca. 70 Minuten ab dem 04.09. jeweils dienstags ab ca. 23:00 gesendet. Positive Daten einer Phase-1b-Studie von ABX-1431 bei Tourette-Syndrom Diese Veröffentlichung enthält Details zu

Kooperation mit Frau. Prof.in A. Melk, Pädiatrische Nephrologie), die Auswertung von Sekundärdaten (Krankenkassendaten der AOK Niedersachsen in Kooperation mit Prof. S. Geyer und Dr. J. Epping, Medizinische [...] , die Bearbeitung von eigenen Fragestellungen in vorhandenen großen Datenbanken (u.a. NHANES, ANZ-Data) und die Analyse dieser Daten mit modernen Regressionsmodellen. Da es ein Merkmal unseres Fachgebietes [...] Schmidt BMW, Kielstein JT. Safety and efficacy of the Seraph® 100 Microbind® Affinity Blood Filter to remove bacteria from the blood stream: results of the first in human study. Crit Care. 2022 Jun 17

Barros Martins (Immunologie) Titel: A mix and match story: understanding the immune system responses to heterologous or homologous ChAdOx1nCoV-19/BTN162b2 vaccination against SARS-CoV-2 Moderation: Dr. Swantje [...] 2022 Vortrag: Shambhabi Chatterjee, PhD (IMTTS) Titel: Exploration and exploitation of non-coding RNAs to prevent SARS-CoV-2 infection in cardiomyocytes Moderation: PD Dr. Christian Bär (IMTTS) Juni 14. Juni [...] (Rheumatologie und Immunologie) 28. Juni 2022 Vortrag: PD Dr. Arno Kerling (Sportmedizin) Titel: "Return to Sports" nach COVID-19-Erkrankung Mai 1 6. Mai 2022 Vortrag: PD Nicole de Buhr, PhD (Institut für Biochemie

competitive advantage of these mutant pre-leukemic cells remains poorly understood to date. Therefore, therapeutic interventions to prevent clonal evolution and ultimately blood cancer development have yet not [...] will be addressed in this project. To date, DNA methylation and chromatin biology are largely regarded as separate epigenetic regulatory principles. Our work aims to connect these epigenetic entities in [...] Oncology in October 2023. The Price honored his contribution to the understanding of the molecular mechanisms underlying responses of leukemia cells to treatment with inhibitors of the Menin-MLL1-Interaction

Einverständnis für die Verarbeitung dieser Daten dar. Dies gilt auch für übermittelte besondere Kategorien personenbezogener Daten, wie etwa Gesundheitsdaten. Diese verarbeitet die MHH gemäß Art. 9 Abs [...] Dauer der Speicherung personenbezogener Daten: Ihre personenbezogenen Daten werden auf dem Server des Rechenzentrums der MHH gemäß den datenschutzrechtlichen Vorschriften, insbs. der DSGVO, gespeichert [...] sten bezogen auf die speziellen Datenkategorien, für die jeweilige Aufgabenerfüllung erforderlich ist. Alle personenbezogenen Daten werden nach dem sogenannten „Need-to-Know“ Prinzip behandelt und so früh

Ad protein known to date. Unlike the other E3 proteins that act directly on infected cells, Sec49K can affect host immune functions over a distance by targeting leukocytes via binding to the cell surface [...] predicted to form immunoglobulin-like domains. E3/49K exhibits a novel processing pathway for E3 proteins. Approximately 1 h after synthesis it is cleaved by a matrix metalloprotease N-terminal to the tr [...] disease, but can also establish persistent infections. In immunocompromised patients, Ad infections tend to be severe or even fatal. The disease pattern differs between Ad species. Species A, F and G are associated